Skip to main content
Equibles

DAFNA Capital Management LLC

Position in FATE — Fate Therapeutics Inc

CIK 1389933 LOS ANGELES, CA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,417,500
+$757,500 QoQ
Shares Held
525,000
-4.5% QoQ
Ownership
0.438%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#24
of 156 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. FATE ranks #39 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in FATE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,417,500 525,000
2026-03-31 $660,000 550,000
2025-12-31 $539,000 550,000
2022-12-31 $5,558,984 550,940
2022-09-30 $12,100,055 539,940
2022-06-30 $13,652,293 550,940
2022-03-31 $19,421,056 500,930
2021-12-31 $21,775,081 372,160
2021-09-30 $20,410,217 344,360
2021-06-30 $27,283,304 314,360
2021-03-31 $25,918,982 314,360
2020-12-31 $30,403,354 334,360
2020-09-30 $17,525,246 438,460
2020-06-30 $16,841,440 490,861
2020-03-31 $10,438,700 470,000